1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Liu, G.
Poppe, L.
Aoki, K.
Yamane, H.
Lewis, J.
Szyperski, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Plos One
1932-6203
9
e96521
e96521
10.1371/journal.pone.0096521
24789074
High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design.
2014
10.2210/pdb2mhs/pdb
pdb_00002mhs
18866.354
Induced myeloid leukemia cell differentiation protein Mcl-1
UNP residues 171-327
C117S
1
man
polymer
Bcl-2-like protein 3, Bcl2-L-3, Bcl-2-related protein EAT/mcl1, mcl1/EAT
no
no
MEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRV
MIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESSIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGHH
HHHH
MEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRV
MIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESSIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGHH
HHHH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
MCL1, BCL2L3
9606
Homo sapiens
562
Escherichia coli
plasmid
pSR482-21.1
database_2
pdbx_database_status
struct_ref_seq_dif
repository
Initial release
Database references
Other
1
0
2014-05-14
1
1
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_struct_ref_seq_dif.details
BMRB
Y
RCSB
2013-12-04
REL
REL
REL
REL
target function
100
20
3D 15N/13Caliphatic/13Caromatic-resolved NOESY
GFT(4,3)D HNNCabCa
GFT(4,3)DCabCacoNHN
GFT(4,3)D HabCabcoNHN
GFT(4,3)D HNNCO
GFT (4,3)D HCCH
2D 1H-13C HSQC
2D 1H-15N HSQC
2D 1H-13C HSQC
2D 1H-13C HSQC aromatic
0.7
mM
[U-100% 13C; U-100% 15N]
0.7
mM
[U-5% 13C; U-100% 15N]
0.3
7.4
ambient
298
K
distance geometry, molecular dynamics, simulated annealing, torsion angle dynamics
1
lowest energy
0.7 mM [U-100% 13C; U-100% 15N] mcl-1, 95% H2O/5% D2O
95% H2O/5% D2O
0.7 mM [U-5% 13C; U-100% 15N] mcl-1, 95% H2O/5% D2O
95% H2O/5% D2O
Varian
collection
VNMR
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
Bartels et al.
data analysis
XEASY
Zimmerman, Moseley, Kulikowski and Montelione
chemical shift assignment
AutoAssign
Huang, Tejero, Powers and Montelione
structure solution
AutoStructure
Huang, Tejero, Powers and Montelione
data analysis
AutoStructure
Guntert, Mumenthaler and Wuthrich
structure solution
CYANA
Guntert, Mumenthaler and Wuthrich
data analysis
CYANA
Brunger, Adams, Clore, Gros, Nilges and Read
structure solution
CNS
Brunger, Adams, Clore, Gros, Nilges and Read
refinement
CNS
Glaser
processing
SPSCAN
Bhattacharya and Montelione
data analysis
PSVS
750
Varian
INOVA
Varian INOVA
600
Varian
INOVA
Varian INOVA
MET
1
n
1
MET
1
A
GLU
2
n
2
GLU
2
A
ASP
3
n
3
ASP
3
A
GLU
4
n
4
GLU
4
A
LEU
5
n
5
LEU
5
A
TYR
6
n
6
TYR
6
A
ARG
7
n
7
ARG
7
A
GLN
8
n
8
GLN
8
A
SER
9
n
9
SER
9
A
LEU
10
n
10
LEU
10
A
GLU
11
n
11
GLU
11
A
ILE
12
n
12
ILE
12
A
ILE
13
n
13
ILE
13
A
SER
14
n
14
SER
14
A
ARG
15
n
15
ARG
15
A
TYR
16
n
16
TYR
16
A
LEU
17
n
17
LEU
17
A
ARG
18
n
18
ARG
18
A
GLU
19
n
19
GLU
19
A
GLN
20
n
20
GLN
20
A
ALA
21
n
21
ALA
21
A
THR
22
n
22
THR
22
A
GLY
23
n
23
GLY
23
A
ALA
24
n
24
ALA
24
A
LYS
25
n
25
LYS
25
A
ASP
26
n
26
ASP
26
A
THR
27
n
27
THR
27
A
LYS
28
n
28
LYS
28
A
PRO
29
n
29
PRO
29
A
MET
30
n
30
MET
30
A
GLY
31
n
31
GLY
31
A
ARG
32
n
32
ARG
32
A
SER
33
n
33
SER
33
A
GLY
34
n
34
GLY
34
A
ALA
35
n
35
ALA
35
A
THR
36
n
36
THR
36
A
SER
37
n
37
SER
37
A
ARG
38
n
38
ARG
38
A
LYS
39
n
39
LYS
39
A
ALA
40
n
40
ALA
40
A
LEU
41
n
41
LEU
41
A
GLU
42
n
42
GLU
42
A
THR
43
n
43
THR
43
A
LEU
44
n
44
LEU
44
A
ARG
45
n
45
ARG
45
A
ARG
46
n
46
ARG
46
A
VAL
47
n
47
VAL
47
A
GLY
48
n
48
GLY
48
A
ASP
49
n
49
ASP
49
A
GLY
50
n
50
GLY
50
A
VAL
51
n
51
VAL
51
A
GLN
52
n
52
GLN
52
A
ARG
53
n
53
ARG
53
A
ASN
54
n
54
ASN
54
A
HIS
55
n
55
HIS
55
A
GLU
56
n
56
GLU
56
A
THR
57
n
57
THR
57
A
ALA
58
n
58
ALA
58
A
PHE
59
n
59
PHE
59
A
GLN
60
n
60
GLN
60
A
GLY
61
n
61
GLY
61
A
MET
62
n
62
MET
62
A
LEU
63
n
63
LEU
63
A
ARG
64
n
64
ARG
64
A
LYS
65
n
65
LYS
65
A
LEU
66
n
66
LEU
66
A
ASP
67
n
67
ASP
67
A
ILE
68
n
68
ILE
68
A
LYS
69
n
69
LYS
69
A
ASN
70
n
70
ASN
70
A
GLU
71
n
71
GLU
71
A
ASP
72
n
72
ASP
72
A
ASP
73
n
73
ASP
73
A
VAL
74
n
74
VAL
74
A
LYS
75
n
75
LYS
75
A
SER
76
n
76
SER
76
A
LEU
77
n
77
LEU
77
A
SER
78
n
78
SER
78
A
ARG
79
n
79
ARG
79
A
VAL
80
n
80
VAL
80
A
MET
81
n
81
MET
81
A
ILE
82
n
82
ILE
82
A
HIS
83
n
83
HIS
83
A
VAL
84
n
84
VAL
84
A
PHE
85
n
85
PHE
85
A
SER
86
n
86
SER
86
A
ASP
87
n
87
ASP
87
A
GLY
88
n
88
GLY
88
A
VAL
89
n
89
VAL
89
A
THR
90
n
90
THR
90
A
ASN
91
n
91
ASN
91
A
TRP
92
n
92
TRP
92
A
GLY
93
n
93
GLY
93
A
ARG
94
n
94
ARG
94
A
ILE
95
n
95
ILE
95
A
VAL
96
n
96
VAL
96
A
THR
97
n
97
THR
97
A
LEU
98
n
98
LEU
98
A
ILE
99
n
99
ILE
99
A
SER
100
n
100
SER
100
A
PHE
101
n
101
PHE
101
A
GLY
102
n
102
GLY
102
A
ALA
103
n
103
ALA
103
A
PHE
104
n
104
PHE
104
A
VAL
105
n
105
VAL
105
A
ALA
106
n
106
ALA
106
A
LYS
107
n
107
LYS
107
A
HIS
108
n
108
HIS
108
A
LEU
109
n
109
LEU
109
A
LYS
110
n
110
LYS
110
A
THR
111
n
111
THR
111
A
ILE
112
n
112
ILE
112
A
ASN
113
n
113
ASN
113
A
GLN
114
n
114
GLN
114
A
GLU
115
n
115
GLU
115
A
SER
116
n
116
SER
116
A
SER
117
n
117
SER
117
A
ILE
118
n
118
ILE
118
A
GLU
119
n
119
GLU
119
A
PRO
120
n
120
PRO
120
A
LEU
121
n
121
LEU
121
A
ALA
122
n
122
ALA
122
A
GLU
123
n
123
GLU
123
A
SER
124
n
124
SER
124
A
ILE
125
n
125
ILE
125
A
THR
126
n
126
THR
126
A
ASP
127
n
127
ASP
127
A
VAL
128
n
128
VAL
128
A
LEU
129
n
129
LEU
129
A
VAL
130
n
130
VAL
130
A
ARG
131
n
131
ARG
131
A
THR
132
n
132
THR
132
A
LYS
133
n
133
LYS
133
A
ARG
134
n
134
ARG
134
A
ASP
135
n
135
ASP
135
A
TRP
136
n
136
TRP
136
A
LEU
137
n
137
LEU
137
A
VAL
138
n
138
VAL
138
A
LYS
139
n
139
LYS
139
A
GLN
140
n
140
GLN
140
A
ARG
141
n
141
ARG
141
A
GLY
142
n
142
GLY
142
A
TRP
143
n
143
TRP
143
A
ASP
144
n
144
ASP
144
A
GLY
145
n
145
GLY
145
A
PHE
146
n
146
PHE
146
A
VAL
147
n
147
VAL
147
A
GLU
148
n
148
GLU
148
A
PHE
149
n
149
PHE
149
A
PHE
150
n
150
PHE
150
A
HIS
151
n
151
HIS
151
A
VAL
152
n
152
VAL
152
A
GLU
153
n
153
GLU
153
A
ASP
154
n
154
ASP
154
A
LEU
155
n
155
LEU
155
A
GLU
156
n
156
GLU
156
A
GLY
157
n
157
GLY
157
A
GLY
158
n
158
GLY
158
A
HIS
159
n
159
HIS
159
A
HIS
160
n
160
HIS
160
A
HIS
161
n
161
HIS
161
A
HIS
162
n
162
HIS
162
A
HIS
163
n
163
HIS
163
A
HIS
164
n
164
HIS
164
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
20
A
A
HH12
HB2
ARG
LYS
15
28
1.25
1
A
ARG
32
60.98
-80.43
1
A
LEU
66
-82.20
-76.05
1
A
ASP
67
47.21
91.89
1
A
VAL
89
-62.85
-177.54
1
A
THR
90
-87.00
-78.99
1
A
ASN
91
45.41
89.58
1
A
GLN
114
-84.82
45.55
1
A
HIS
151
56.65
72.48
1
A
VAL
152
-103.16
-68.52
1
A
GLU
156
-105.58
-62.64
1
A
HIS
160
-154.16
57.73
2
A
ALA
24
-140.24
-156.62
2
A
PRO
29
-58.23
-77.20
2
A
MET
30
174.63
-30.75
2
A
LEU
66
-99.94
-69.57
2
A
ASP
67
71.70
-48.63
2
A
ILE
68
62.97
98.24
2
A
THR
90
-77.38
20.57
2
A
ASN
91
-68.57
81.00
2
A
GLN
114
-92.74
38.86
2
A
ARG
141
59.84
80.83
2
A
HIS
159
69.86
-61.70
2
A
HIS
160
-44.42
103.86
3
A
ALA
24
-112.06
-159.89
3
A
ARG
32
-104.87
-76.85
3
A
LEU
66
-118.90
-73.66
3
A
ASP
67
70.45
-43.86
3
A
ILE
68
62.83
90.27
3
A
THR
90
63.58
-62.11
3
A
TRP
92
-69.24
11.32
3
A
ARG
141
61.61
60.16
3
A
HIS
159
-42.70
107.64
4
A
THR
27
-148.67
19.96
4
A
LEU
66
-117.18
-76.18
4
A
ASP
67
71.12
-40.72
4
A
ILE
68
60.42
94.25
4
A
PHE
85
-88.57
32.76
4
A
GLN
114
-99.61
36.99
4
A
ARG
141
62.29
89.71
4
A
GLU
156
-140.31
-45.50
5
A
MET
30
-117.14
-83.43
5
A
ASP
67
54.37
97.71
5
A
THR
90
-67.66
86.10
5
A
GLN
114
-91.95
40.84
5
A
ARG
141
51.49
72.17
5
A
HIS
151
65.75
74.83
5
A
ASP
154
-102.62
-164.68
5
A
GLU
156
-115.99
-71.58
5
A
HIS
163
58.00
12.44
6
A
THR
27
-143.27
48.55
6
A
LEU
66
-95.09
-75.70
6
A
ASP
67
43.34
83.37
6
A
PHE
85
-82.50
44.05
6
A
GLN
114
-91.66
43.27
6
A
ARG
141
55.16
74.06
6
A
GLU
153
-131.18
-45.29
7
A
GLU
2
-164.11
-165.85
7
A
THR
27
-141.71
23.98
7
A
ARG
32
-86.77
-82.08
7
A
LEU
66
-103.85
-73.72
7
A
ASP
67
38.26
87.06
7
A
GLN
114
-94.76
38.08
7
A
THR
132
-130.46
-37.41
7
A
HIS
151
71.31
106.54
7
A
VAL
152
-142.05
-73.89
8
A
THR
27
-151.03
22.46
8
A
LEU
66
-82.75
-73.13
8
A
ASP
67
45.35
83.40
8
A
TRP
92
68.19
-25.89
8
A
GLN
114
-81.70
45.42
8
A
HIS
151
54.78
86.71
8
A
VAL
152
-94.43
-61.30
8
A
HIS
162
-163.45
102.65
9
A
THR
27
-141.87
33.08
9
A
LEU
66
-99.83
-82.38
9
A
ASP
67
48.63
98.94
9
A
PHE
85
-79.82
42.45
9
A
GLN
114
-97.95
31.65
9
A
HIS
151
57.61
79.23
9
A
VAL
152
-107.09
-68.52
9
A
GLU
153
-105.77
67.27
9
A
HIS
159
58.38
130.16
10
A
LEU
66
-96.35
-71.66
10
A
ASP
67
47.46
88.85
10
A
GLN
114
-87.52
43.56
10
A
ARG
141
55.63
79.02
10
A
HIS
151
61.08
88.16
10
A
VAL
152
-129.79
-74.93
10
A
GLU
153
-116.41
79.82
10
A
GLU
156
62.18
-1.43
10
A
HIS
160
-78.05
29.18
10
A
HIS
161
-172.10
132.94
11
A
MET
30
-60.28
-71.08
11
A
LEU
66
-97.12
-78.99
11
A
ASP
67
68.11
-47.93
11
A
ILE
68
65.58
114.82
11
A
ILE
112
-95.43
31.78
11
A
ASN
113
48.71
22.18
11
A
GLN
114
-93.61
35.98
11
A
HIS
151
68.19
85.25
11
A
VAL
152
-124.02
-71.41
11
A
GLU
153
-106.81
67.71
11
A
ASP
154
-169.72
-167.06
11
A
LEU
155
-147.93
11.56
12
A
THR
27
-147.27
37.59
12
A
LEU
66
-102.94
-73.97
12
A
ASP
67
40.95
84.65
12
A
ILE
68
-59.60
104.99
12
A
VAL
152
-102.41
-60.21
12
A
GLU
156
63.07
84.31
12
A
HIS
159
-141.49
55.02
12
A
HIS
162
53.92
0.56
13
A
THR
27
-144.28
-5.80
13
A
ARG
32
-155.64
-76.64
13
A
LEU
66
-81.95
-80.82
13
A
ASP
67
45.24
90.44
13
A
THR
132
-130.18
-30.78
14
A
PRO
29
-66.33
72.76
14
A
MET
30
37.44
-89.46
14
A
ARG
32
-137.66
-64.42
14
A
LEU
66
-69.56
-76.72
14
A
ASP
67
43.67
85.70
14
A
THR
90
-68.61
84.15
14
A
GLN
114
-86.22
35.62
14
A
THR
132
-131.44
-40.82
14
A
ARG
141
60.62
83.78
14
A
HIS
151
60.41
81.47
14
A
VAL
152
-129.59
-67.39
14
A
GLU
153
-119.75
69.42
14
A
GLU
156
80.20
-60.85
14
A
HIS
160
-55.46
106.50
15
A
LEU
66
-89.58
-74.87
15
A
ASP
67
34.29
91.03
15
A
THR
90
-91.68
52.69
15
A
ARG
141
52.81
71.79
15
A
GLU
156
-134.08
-67.19
15
A
HIS
159
-69.59
91.54
16
A
THR
27
-94.76
31.68
16
A
LEU
66
-96.23
-69.70
16
A
ASP
67
69.63
-52.08
16
A
ILE
68
64.94
99.49
16
A
SER
86
-78.48
41.60
16
A
GLN
114
-82.72
33.69
16
A
HIS
151
65.27
71.91
16
A
GLU
156
65.68
-13.93
16
A
HIS
163
173.38
168.82
17
A
THR
27
-149.85
11.51
17
A
PRO
29
-49.42
107.15
17
A
SER
33
-89.05
-74.67
17
A
LEU
66
-95.95
-71.86
17
A
ASP
67
44.27
87.73
17
A
ASP
87
-60.67
-70.26
17
A
TRP
92
63.86
-5.06
17
A
LYS
133
-150.33
48.90
17
A
VAL
152
-100.33
-69.92
17
A
GLU
153
-100.89
68.16
17
A
GLU
156
-147.06
-60.22
17
A
HIS
160
53.99
18.92
18
A
THR
27
-150.44
41.60
18
A
LEU
66
-105.92
-84.78
18
A
ASP
67
67.75
-22.41
18
A
ILE
68
59.34
95.65
18
A
ASP
87
-66.02
85.37
18
A
GLN
114
-82.87
40.92
19
A
THR
27
-152.28
29.13
19
A
SER
33
63.55
88.19
19
A
LEU
66
-90.25
-77.32
19
A
ASP
67
52.52
91.93
19
A
ASN
113
47.70
20.41
19
A
GLN
114
-89.17
35.71
19
A
HIS
151
44.59
86.49
20
A
ALA
24
-124.16
-163.89
20
A
THR
27
-140.05
25.83
20
A
LEU
66
-88.73
-83.47
20
A
ASP
67
49.56
94.56
20
A
THR
90
-84.94
35.62
20
A
ASN
113
48.94
21.73
20
A
GLN
114
-90.62
35.88
20
A
HIS
151
61.33
78.76
20
A
VAL
152
-118.45
-72.05
20
A
GLU
156
-134.32
-58.31
NMR Structure of human Mcl-1
1
N
N
A
ASP
3
A
ASP
3
HELX_P
A
GLY
23
A
GLY
23
1
1
21
A
SER
33
A
SER
33
HELX_P
A
ASP
67
A
ASP
67
1
2
35
A
ASN
70
A
ASN
70
HELX_P
A
VAL
84
A
VAL
84
1
3
15
A
ASN
91
A
ASN
91
HELX_P
A
ILE
112
A
ILE
112
1
4
22
A
GLN
114
A
GLN
114
HELX_P
A
LYS
133
A
LYS
133
1
5
20
A
LYS
133
A
LYS
133
HELX_P
A
GLN
140
A
GLN
140
1
6
8
A
ARG
141
A
ARG
141
HELX_P
A
PHE
150
A
PHE
150
1
7
10
APOPTOSIS
Mcl-1, Bcl-2 family, BH domain, Apoptosis, Cancer drug, GFT NMR
MCL1_HUMAN
UNP
1
171
Q07820
EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVM
IHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG
171
327
2MHS
2
158
Q07820
A
1
2
158
1
initiating methionine
MET
1
2MHS
A
Q07820
UNP
1
1
CYS
engineered mutation
SER
117
2MHS
A
Q07820
UNP
286
117
1
expression tag
HIS
159
2MHS
A
Q07820
UNP
159
1
expression tag
HIS
160
2MHS
A
Q07820
UNP
160
1
expression tag
HIS
161
2MHS
A
Q07820
UNP
161
1
expression tag
HIS
162
2MHS
A
Q07820
UNP
162
1
expression tag
HIS
163
2MHS
A
Q07820
UNP
163
1
expression tag
HIS
164
2MHS
A
Q07820
UNP
164